Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy

Launched by REGION ÖREBRO COUNTY · Jan 10, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring how a tool called a Question Prompt List (QPL) can help women with early-stage breast cancer make informed decisions about their treatment before surgery, specifically regarding neoadjuvant chemotherapy (a type of chemotherapy given before surgery). The trial aims to see if using the QPL improves communication between patients and doctors, helps patients understand their treatment options better, reduces anxiety about their decisions, and encourages them to participate more actively in the decision-making process.

To be eligible for this trial, participants must be women aged 65 to 74 who have operable breast cancer and qualify for neoadjuvant therapy based on current treatment guidelines. Patients who have more advanced breast cancer where this type of treatment is mandatory, those with cognitive impairments, or those who cannot read or speak Swedish or English cannot participate. If you join this study, you can expect to engage in helpful discussions with your healthcare team, using the QPL to make sure all your questions are answered and your concerns are heard. This could lead to a clearer understanding of your treatment options and a more confident decision-making experience.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Patients with operable breast cancer eligible for systemic neoadjuvant therapy, according to current treatment guidelines.
• Exclusion Criteria:
• • Patients with locally advanced breast cancer where neoadjuvant therapy is mandatory rather than a treatment option.
• • Patients with cognitive impairment that are assessed from treating physician as unable to participate.
• • Patients who cannot speak/read neither Swedish nor English.